Clinical Trial Update: Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide

View source ↗

Summary

A completed clinical trial evaluating the effectiveness, safety, adherence, and health-related quality of life in adults with HIV-1 infection treated with Bicte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Status: COMPLETED